Retractable Technologies Inc (RVP) Stock Price & Analysis
Retractable Technologies Inc (RVP) rose 0.16% to USD 0.69 as of June 10, 2026 at 03:31 UTC, according to Nexqual real-time market data.
RVP last closed at USD 0.69; the session ranged USD 0.65–0.69 on volume of 52,371 shares. Market capitalization is $20.60M, with a 52-week range of USD 0.6–1.14 (ASE). Source: Nexqual, June 10, 2026 at 03:31 UTC.
Key Statistics (as of June 10, 2026 at 03:31 UTC)
| Price | USD 0.69 |
|---|---|
| Change | ▲ 0.16% (up) |
| Previous Close | USD 0.69 |
| Open | USD 0.67 |
| Day Range | USD 0.65 – 0.69 |
| 52-Week Range | USD 0.6 – 1.14 |
| Volume | 52,371 shares |
| Market Cap | $20.60M |
| Exchange | ASE |
Technical Analysis (RVP)
Nexqual's technical model rates RVP "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 03:31 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 51.89 (neutral) |
| vs SMA50 | Above (USD 0.68) |
| MACD | 0 (positive) |
Analyst Ratings (RVP)
Wall Street analysts rate RVP "None", per Nexqual as of June 10, 2026 at 03:31 UTC.
| Consensus Rating | None |
|---|
Earnings (RVP)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2010-12-31 | USD -0.04 vs est 0.02 ▼ miss |
Source: Nexqual, June 10, 2026 at 03:31 UTC.
Financials & Fundamentals (RVP)
| Total Revenue | $37.15M |
|---|---|
| Revenue Growth (YoY) | -13.50% |
| Gross Margin | -2.13% |
| Operating Margin | -85.93% |
| Profit Margin | -16.93% |
| ROE | -8.58% |
| Debt / Equity | 1.7 |
| Current Ratio | 5.74 |
| Total Cash | $35.62M |
| Total Debt | $1.19M |
| Free Cash Flow | $-1.96M |
Source: Nexqual, June 10, 2026 at 03:31 UTC.
Financial Health Score (RVP)
Nexqual rates Retractable Technologies Inc's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:31 UTC.
| Growth | Critical — Revenue -14% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $36M cash vs $1M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Critical — ROE -9%, ROA -9.5% |
Ownership (RVP)
| Insider Ownership | +59.23% |
|---|---|
| Institutional Ownership | +8.32% |
| Shares Outstanding | 29.94M |
| Float | 12.21M |
| Short % of Float | +0.22% |
Source: Nexqual, June 10, 2026 at 03:31 UTC.
Leadership (RVP)
Retractable Technologies Inc is led by Thomas J. Shaw (age 74), Founder, Chairman, President & CEO, per Nexqual as of June 10, 2026 at 03:31 UTC.
| Founder, Chairman, President & CEO | Thomas J. Shaw (age 74) |
|---|---|
| VP, CFO, Principal Accounting Officer,Treasurer & Director | John W. Fort (age 56) |
| Director of Operations | Lawrence G. Salerno (age 65) |
| Vice President of Sales | Kevin McGlinchey |
Major Backers & Investors (RVP)
Notable institutional backers of Retractable Technologies Inc include Eversept Partners, LP, Renaissance Technologies, Fidelity, according to Nexqual as of June 10, 2026 at 03:31 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Eversept Partners, LP | 1.94% |
| Renaissance Technologies | 1.35% |
| Fidelity | 0.43% |
| Bridgeway Capital Management, LLC | 0.3% |
| Bridgeway Funds, Inc.-Ultra-Small Company Market Fund | 0.24% |
| Wealthtrust Axiom, LLC | 0.18% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 4.17% |
| BlackRock | 0.81% |
| Geode Capital | 0.5% |
| State Street | 0.2% |
Source: Nexqual, June 10, 2026 at 03:31 UTC.
From Retractable Technologies Inc's Latest SEC 10-K Filing (filed 2026-03-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
- The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
- It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MLSS | Milestone Scientific, Inc. | USD 0.39 | ▼ 8.1% |
| PRTS | CarParts.com, Inc. | USD 5.95 | ▼ 0.5% |
| IMDX | Insight Molecular Diagnostics I | USD 5.85 | ▲ 11.64% |
| APT | Alpha Pro Tech, Ltd. | USD 5.37 | ▲ 4.68% |
| INFU | InfuSystems Holdings, Inc. | USD 9.01 | ▼ 2.49% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:31 UTC. This page is informational and not investment advice.